House dust mite

Type: Keyphrase
Name: House dust mite
First reported Jul 26 2014 - Updated Jul 26 2014 - 1 reports

Researchers Create Vaccine For Dust Mite Allergies

Image Caption: Dust mites are tiny and ubiquitous, but they cause big allergic reactions for many people. University of Iowa researchers have created a vaccine that may provide relief to dust-mite allergies. Credit: Illustration by Austin Smoldt-Sáen ... [Published Red Orbit - Jul 26 2014]
First reported Jun 24 2014 - Updated Jun 24 2014 - 1 reports

Allergy hospital admissions continue to soar

Comments (0)Medical Specialists™ Pharmacy discuss the rising number of hospital admissions relating to allergies and how the Western diet may be partially to blame.Bury, Manchester (PRWEB UK) 10 June 2014An increasing number of patients are requiring ... [Published Leicester Mercury - Jun 24 2014]
First reported Jun 13 2014 - Updated Jun 13 2014 - 1 reports

Circassia Announces Results from Phase IIb Study

-- Circassia Announces Results from House Dust Mite Allergy Treatment Phase IIb Two-Year Follow-up Study --Oxford, UK - 13 June 2014: Circassia Pharmaceuticals plc ("Circassia" or "the Company") (LSE: CIR), a clinical-stage specialty biopharmaceutical ... [Published TrustNet - Jun 13 2014]
First reported Jun 10 2014 - Updated Jun 11 2014 - 1 reports

Allergy hospital admissions continue to soar

Medical Specialists™ Pharmacy discuss the rising number of hospital admissions relating to allergies and how the Western diet may be partially to blame. An increasing number of patients are requiring hospital treatment due to allergic reactions, and health ... [Published PRWeb - Jun 10 2014]
First reported Apr 25 2014 - Updated Apr 25 2014 - 1 reports

ALK enters collaboration to accelerate growth in China

Copenhagen, 2014-04-25 04:00 CEST (GLOBE NEWSWIRE) --ALK (ALK-B.CO / OMX: ALK B / AKABY / AKBLF) and China-based specialty pharmaceutical company Eddingpharm, today announced that they have agreed a collaboration that will expand ALK’s presence in China. ... [Published GlobeNewswire - Apr 25 2014]

Quotes

Commenting on the statistics in a statement, Maureen Jenkins, director of clinical services at Allergy UK, said: "These shocking statistics reflect the very worrying situation of the consequences of allergy-related diseases in the UK. It is not only the incidence of food allergy, anaphylaxis, rhinitis and eczema that is on the increase but also the severity of these conditions, including asthma, which still kills more than 1,000 people annually, most of which are preventable."
Jens Bager, President and CEO of ALK said: "ALK's affiliate in China, set up in 2004, has consistently delivered strong year-on-year growth for the company. This collaboration will allow us to accelerate our expansion in China by securing a threefold increase in sales force size, and allowing ALK's products to benefit from Eddingpharm's established position in respiratory medicine."
Steve Harris, Circassia's Chief Executive, said: "These encouraging trends suggest that our short-course house dust mite allergy treatment has lasting effects two years on with no further injections.  Results from long-term follow-up studies, even with smaller patient numbers, are invaluable for informing the design of future clinical studies across our portfolio of product candidates.  We believe our short-course SPIRE treatments could offer significant benefits and, having completed 18 clinical studies, our late-stage data set continues to underline our confidence in the ToleroMune® platform technology."

More Content

All (7) | News (5) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (1)
sort by: Date | Relevance
Researchers Create Vaccine For Dust Mite Allergies [Published Red Orbit - Jul 26 2014]
Allergy hospital admissions continue to soar [Published Leicester Mercury - Jun 24 2014]
ALK enters collaboration to accelerate growth i... [Published OrbiMed Advisors - Jun 21 2014]
Circassia Announces Results from Phase IIb Study [Published TrustNet - Jun 13 2014]
Allergy hospital admissions continue to soar [Published PRWeb - Jun 10 2014]
ALK enters collaboration to accelerate growth i... [Published GlobeNewswire - Apr 25 2014]
House dust mite SLIT-tablet enters Phase III cl... [Published GlobeNewswire: Advertising News - Mar 20 2014]
1
Content Volume
Document Volume
Network
Network

Press Releases

sort by: Date | Relevance
House dust mite SLIT-tablet enters Phase III cl... [Published GlobeNewswire: Advertising News - Mar 20 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.